Episode Details

Canada’s drug supply is dangerously fragile—relying on imports for 70% of meds while contributing just 2% of the global market, leaving us vulnerable to international disruptions that directly impact patients and healthcare providers. Experts warn we must overhaul the entire supply chain—from manufacturing to distribution—to build a resilient system that guarantees consistent access to essential medicines, no matter what happens abroad.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/fed8f73afb03ba42